Amid dual mental health and substance use disorder crises, board-certified psychiatric pharmacists can address shortage of behavioral health providers, USC expert writes in Psychiatry Online.
The Food and Drug Administration yanked the fight against Alzheimer’s out of the mire with its approval of the first disease-modifying therapy. Although it’s a modest first step, it paves the way for more momentous breakthroughs.
Black and Latino neighborhoods in the 30 most populous U.S. cities had fewer pharmacies than white or diverse neighborhoods in 2007-2015, USC research shows, suggesting that ‘pharmacy deserts’ may be an overlooked contributor to persistent racial and ethnic health disparities.
The City’s vaccination program administered its one millionth dose, reaching a major milestone in its efforts to vaccinate Angelenos and bring the pandemic to an end.
The USC School of Pharmacy has partnered with the City of Los Angeles to provide free flu vaccinations at various COVID-19 testing locations across the city.
USC Schaeffer Center for Health Policy & Economics is launching a new multi-site Alzheimer’s Disease Center, led in part by Dana Goldman, distinguished professor at the USC School of Pharmacy.
Humanity has never seen a global research collaboration on this scale — but USC experts including Frances Richmond of the USC School of Pharmacy note that the vaccine development and approval process remains a long and laborious one.
Daniel Tomaszewski, PharmD, PhD, is joining the faculty of the department of pharmaceutical and health economics as associate professor of pharmaceutical and health economics.
